Cargando…

Assessment of Olfactory Threshold in Patients Undergoing Radiotherapy for Head and Neck Malignancies

INTRODUCTION: Radiotherapy is a common treatment modality for patients with head and neck malignancies. As the nose lies within the field of radiotherapy of the head and neck, the olfactory fibers and olfactory receptors may be affected by radiation. The aim of this study was to evaluate changes in...

Descripción completa

Detalles Bibliográficos
Autores principales: Jalali, Mir Mohammad, Gerami, Hooshang, Rahimi, Abbas, Jafari, Manizheh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196444/
https://www.ncbi.nlm.nih.gov/pubmed/25320698
_version_ 1782339476879572992
author Jalali, Mir Mohammad
Gerami, Hooshang
Rahimi, Abbas
Jafari, Manizheh
author_facet Jalali, Mir Mohammad
Gerami, Hooshang
Rahimi, Abbas
Jafari, Manizheh
author_sort Jalali, Mir Mohammad
collection PubMed
description INTRODUCTION: Radiotherapy is a common treatment modality for patients with head and neck malignancies. As the nose lies within the field of radiotherapy of the head and neck, the olfactory fibers and olfactory receptors may be affected by radiation. The aim of this study was to evaluate changes in olfactory threshold in patients with head and neck malignancies who have received radiation to the head and neck. MATERIALS AND METHODS: The olfactory threshold of patients with head and neck malignancies was assessed prospectively before radiation therapy and serially for up to 6 months after radiotherapy using sniff bottles. In vivo dosimetry was performed using 82 LiF (MCP) chips and a thermoluminescent dosimeter (TLD) system. RESULTS: Sixty-one patients were recruited before radiotherapy was commenced. Seven patients did not return for evaluation after radiation. Fifty-four patients were available for follow-up assessment (28 women, 26 men; age, 22–86 years; median, 49 years). Total radiation dose was 50.1 Gy (range, 30–66 Gy). Mean olfactory threshold scores were found to deteriorate significantly at various timepoints after radiotherapy (11.7 before radiotherapy versus 4.0 at Month 6, general linear model, P<0.0001). With in vivo dosimetry, we found that the median measured dose to the olfactory area was 334 µC. We also identified a cutoff point according to the dose to the olfactory epithelium. Olfactory threshold was significantly decreased 2–6 weeks after initiation of therapy, with cumulative local radiation >135 µC (Mann-Whitney U test, P=0.01). CONCLUSION: Deterioration in olfactory threshold scores was found at 6 months after initiation of radiation therapy. Provided that these results are reproducible, an evaluation of olfactory functioning in patients with head and neck malignancies using in vivo dosimetry may be useful for determining the optimal dose for patients treated with conformal radiotherapy techniques while avoiding the side effects of radiation.
format Online
Article
Text
id pubmed-4196444
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Mashhad University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-41964442014-10-15 Assessment of Olfactory Threshold in Patients Undergoing Radiotherapy for Head and Neck Malignancies Jalali, Mir Mohammad Gerami, Hooshang Rahimi, Abbas Jafari, Manizheh Iran J Otorhinolaryngol Original Article INTRODUCTION: Radiotherapy is a common treatment modality for patients with head and neck malignancies. As the nose lies within the field of radiotherapy of the head and neck, the olfactory fibers and olfactory receptors may be affected by radiation. The aim of this study was to evaluate changes in olfactory threshold in patients with head and neck malignancies who have received radiation to the head and neck. MATERIALS AND METHODS: The olfactory threshold of patients with head and neck malignancies was assessed prospectively before radiation therapy and serially for up to 6 months after radiotherapy using sniff bottles. In vivo dosimetry was performed using 82 LiF (MCP) chips and a thermoluminescent dosimeter (TLD) system. RESULTS: Sixty-one patients were recruited before radiotherapy was commenced. Seven patients did not return for evaluation after radiation. Fifty-four patients were available for follow-up assessment (28 women, 26 men; age, 22–86 years; median, 49 years). Total radiation dose was 50.1 Gy (range, 30–66 Gy). Mean olfactory threshold scores were found to deteriorate significantly at various timepoints after radiotherapy (11.7 before radiotherapy versus 4.0 at Month 6, general linear model, P<0.0001). With in vivo dosimetry, we found that the median measured dose to the olfactory area was 334 µC. We also identified a cutoff point according to the dose to the olfactory epithelium. Olfactory threshold was significantly decreased 2–6 weeks after initiation of therapy, with cumulative local radiation >135 µC (Mann-Whitney U test, P=0.01). CONCLUSION: Deterioration in olfactory threshold scores was found at 6 months after initiation of radiation therapy. Provided that these results are reproducible, an evaluation of olfactory functioning in patients with head and neck malignancies using in vivo dosimetry may be useful for determining the optimal dose for patients treated with conformal radiotherapy techniques while avoiding the side effects of radiation. Mashhad University of Medical Sciences 2014-10 /pmc/articles/PMC4196444/ /pubmed/25320698 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Jalali, Mir Mohammad
Gerami, Hooshang
Rahimi, Abbas
Jafari, Manizheh
Assessment of Olfactory Threshold in Patients Undergoing Radiotherapy for Head and Neck Malignancies
title Assessment of Olfactory Threshold in Patients Undergoing Radiotherapy for Head and Neck Malignancies
title_full Assessment of Olfactory Threshold in Patients Undergoing Radiotherapy for Head and Neck Malignancies
title_fullStr Assessment of Olfactory Threshold in Patients Undergoing Radiotherapy for Head and Neck Malignancies
title_full_unstemmed Assessment of Olfactory Threshold in Patients Undergoing Radiotherapy for Head and Neck Malignancies
title_short Assessment of Olfactory Threshold in Patients Undergoing Radiotherapy for Head and Neck Malignancies
title_sort assessment of olfactory threshold in patients undergoing radiotherapy for head and neck malignancies
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196444/
https://www.ncbi.nlm.nih.gov/pubmed/25320698
work_keys_str_mv AT jalalimirmohammad assessmentofolfactorythresholdinpatientsundergoingradiotherapyforheadandneckmalignancies
AT geramihooshang assessmentofolfactorythresholdinpatientsundergoingradiotherapyforheadandneckmalignancies
AT rahimiabbas assessmentofolfactorythresholdinpatientsundergoingradiotherapyforheadandneckmalignancies
AT jafarimanizheh assessmentofolfactorythresholdinpatientsundergoingradiotherapyforheadandneckmalignancies